Abstract
‘Masked hypertension’ is defined as having non-elevated clinic blood pressure (BP) with elevated out-of-clinic average BP, typically determined by ambulatory BP monitoring. Approximately 15–30% of adults with non-elevated clinic BP have masked hypertension. Masked hypertension is associated with increased risks of cardiovascular morbidity and mortality compared with sustained normotension (non-elevated clinic and ambulatory BP), which is similar to or approaching the risk associated with sustained hypertension (elevated clinic and ambulatory BP). The confluence of increased cardiovascular risk and a failure to be diagnosed by the conventional approach of clinic BP measurement makes masked hypertension a significant public health concern. However, many important questions remain. First, the definition of masked hypertension varies across studies. Further, the best approach in the clinical setting to exclude masked hypertension also remains unknown. It is unclear whether home BP monitoring is an adequate substitute for ambulatory BP monitoring in identifying masked hypertension. Few studies have examined the mechanistic pathways that may explain masked hypertension. Finally, scarce data are available on the best approach to treating individuals with masked hypertension. Herein, we review the current literature on masked hypertension including definition, prevalence, clinical implications, special patient populations, correlates, issues related to diagnosis, treatment and areas for future research.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 12 digital issues and online access to articles
$119.00 per year
only $9.92 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
References
Myers MG, Valdivieso M, Kiss A . Use of automated office blood pressure measurement to reduce the white coat response. J Hypertens 2009; 27 (2): 280–286.
Pickering TG . How common is white coat hypertension? JAMA 1988; 259 (2): 225–228.
Fagard RH, Cornelissen VA . Incidence of cardiovascular events in white-coat, masked and sustained hypertension versus true normotension: a meta-analysis. J Hypertens 2007; 25 (11): 2193–2198.
Mancia G, Facchetti R, Bombelli M, Grassi G, Sega R . Long-term risk of mortality associated with selective and combined elevation in office, home, and ambulatory blood pressure. Hypertension 2006; 47: 846–853.
Pickering TG, Davidson K, Gerin W, Schwartz JE . Masked hypertension. Hypertension 2002; 40 (6): 795–796.
O’Brien E, Asmar R, Beilin L, Imai Y, Mancia G, Mengden T et al. Practice guidelines of the European Society of Hypertension for clinic, ambulatory and self blood pressure measurement. J Hypertens 2005; 23 (4): 697.
Hansen TW, Jeppesen J, Rasmussen S, Ibsen H, Torp-Pedersen C . Ambulatory blood pressure monitoring and risk of cardiovascular disease: a population based study. Am J Hypertens 2006; 19 (3): 243–250.
Shimbo D, Newman JD, Schwartz JE . Masked hypertension and prehypertension: diagnostic overlap and interrelationships with left ventricular mass: the Masked Hypertension Study. Am J Hypertens 2012; 25 (6): 664–671.
Ohkubo T, Kikuya M, Metoki H, Asayama K, Obara T, Hashimoto J et al. Prognosis of ‘masked’ hypertension and ‘white-coat’ hypertension detected by 24-h ambulatory blood pressure monitoring 10-year follow-up from the Ohasama study. J Am Coll Cardiol 2005; 46 (3): 508–515.
Viera AJ, Hinderliter AL, Kshirsagar AV, Fine J, Dominik R . Reproducibility of masked hypertension in adults with untreated borderline office blood pressure: comparison of ambulatory and home monitoring. Am J Hypertens 2010; 23 (11): 1190–1197.
Boggia J, Li Y, Thijs L, Hansen TW, Kikuya M, Björklund-Bodegård K et al. Prognostic accuracy of day versus night ambulatory blood pressure: a cohort study. Lancet 2007; 370: 1219–1229.
O’Brien E, Parati G, Stergiou G, Asmar R, Beilin L, Bilo G et al. European Society of Hypertension position paper on ambulatory blood pressure monitoring. J Hypertens 2013; 31 (9): 1731–1768.
Pogue V, Rahman M, Lipkowitz M, Toto R, Miller E, Faulkner M et al. Disparate estimates of hypertension control from ambulatory and clinic blood pressure measurements in hypertensive kidney disease. Hypertension 2009; 53 (1): 20–27.
Obara T, Ohkubo T, Kikuya M, Asayama K, Metoki H, Inoue R et al. Prevalence of masked uncontrolled and treated white-coat hypertension defined according to the average of morning and evening home blood pressure value: from the Japan Home versus Office Measurement Evaluation Study. Blood Press Monit 2005; 10: 311–316.
Bjorklund K, Lind L, Zethelius B, Andren B, Lithell H . Isolated ambulatory hypertension predicts cardiovascular morbidity in elderly men. Circulation 2003; 107 (9): 1297–1302.
Hansen TW, Kikuya M, Thijs L, Björklund-Bodegård K, Kuznetsova T, Ohkubo T et al. Prognostic superiority of daytime ambulatory over conventional blood pressure in four populations: a meta-analysis of 7,030 individuals. J Hypertens 2007; 25 (8): 1554–1564.
Franklin SS, Thijs L, Li Y, Hansen TW, Boggia J, Liu Y et al. Masked hypertension in diabetes mellitus: treatment implications for clinical practice. Hypertension 2013; 61 (5): 964–971.
Ben-Dov IZ, Kark JD, Mekler J, Shaked E, Bursztyn M . The white coat phenomenon is benign in referred treated patients: a 14-year ambulatory blood pressure mortality study. J Hypertens 2008; 26: 699–705.
Leitao CB, Canani LH, Silveiro SP, Gross JL . Ambulatory blood pressure monitoring and type 2 diabetes mellitus. Arq Brasil Cardiol 2007; 89 (315–321): 347–354.
Ben-Dov IZ, Ben-Ishay D, Mekler J, Ben-Arie L, Bursztyn M . Increased prevalence of masked blood pressure elevations in treated diabetic subjects. Arch Intern Med 2007; 167: 2139–2142.
Gorostidi M, Sarafidis PA, la Sierra de A, Segura J, la Cruz de JJ, Banegas JR et al. Differences between office and 24-hour blood pressure control in hypertensive patients with CKD: A 5,693-patient cross-sectional analysis from Spain. Am J Kidney Dis 2013; 62 (2): 285–294.
Baguet JP, Levy P, Barone-Rochette G, Tamisier R, Pierre H, Peeters M et al. Masked hypertension in obstructive sleep apnea syndrome. J Hypertens 2008; 26 (5): 885–892.
Drager LF, Diegues-Silva L, Diniz PM, Bortolotto LA, Pedrosa RP, Couto RB et al. Obstructive sleep apnea, masked hypertension, and arterial stiffness in men. Am J Hypertens 2010; 23 (3): 249–254.
Drager LF, Pedrosa RP, Diniz PM, Diegues-Silva L, Marcondes B, Couto RB et al. The effects of continuous positive airway pressure on prehypertension and masked hypertension in men with severe obstructive sleep apnea. Hypertension 2011; 57: 549–555.
Akilli H, Kayrak M, Arıbas A, Tekinalp M, Ayhan SS, Gündüz M et al. The relationship between exercise capacity and masked hypertension in sedentary patients with diabetes mellitus. Clin Exp Hypertens 2013; 36 (1): 9–16.
Verberk WJ, Kessels AGH, de Leeuw PW . Prevalence, causes, and consequences of masked hypertension: a meta-analysis. Am J Hypertens 2008; 21 (9): 969–975.
Sharman JE, Hare JL, Thomas S, Davies JE, Leano R, Jenkins C et al. Association of masked hypertension and left ventricular remodeling with the hypertensive response to exercise. Am J Hypertens 2011; 24 (8): 898–903.
Kramer CK, Leitão CB, Canani LH, Ricardo ED, Pinto LC, Gross JL . Blood pressure responses to exercise in type II diabetes mellitus patients with masked hypertension. J Hum Hypertens 2009; 23: 620–622.
Trudel X, Brisson C, Milot A . Job strain and masked hypertension. Psychosom Med 2010; 72: 786–793.
Landsbergis PA, Travis A, Schnall PL . Working conditions and masked hypertension. High Blood Press Cardiovasc Prev 2013; 20 (2): 69–76.
Landsbergis PA, Dobson M, Koutsouras G, Schnall P . Job strain and ambulatory blood pressure: a meta-analysis and systematic review. Am J Public Health 2013; 103 (3): e61–e71.
Ishikawa J, Kario K, Eguchi K, Morinari M, Hoshide S, Ishikawa S et al. Regular alcohol drinking is a determinant of masked morning hypertension detected by home blood pressure monitoring in medicated hypertensive patients with well-controlled clinic blood pressure: the Jichi Morning Hypertension Research (J-MORE) study. Hypertens Res 2006; 29 (9): 679–686.
Veerabhadrappa P, Diaz KM, Feairheller DL, Sturgeon KM, Williamson ST, Crabbe DL et al. Endothelial-dependent flow-mediated dilation in African Americans with masked-hypertension. Am J Hypertens 2011; 24 (10): 1102–1107.
Bobrie G, Chatellier G, Genes N, Clerson P, Vaur L, Vaisse B et al. Cardiovascular prognosis of ‘masked hypertension’ detected by blood pressure self-measurement in elderly treated hypertensive patients. JAMA 2004; 291: 1342–1349.
Zhuo S, Wen W, Li-Yuan M, Shu-Yu W, Yi-Xin W . Home blood pressure measurement in prehypertension and untreated hypertension: comparison with ambulatory blood pressure monitoring and office blood pressure. Blood Press Monit 2009; 14: 245–250.
Stergiou GS, Argyraki KK, Moyssakis I, Mastorantonakis SE, Achimastos AD, Karamanos VG et al. Home blood pressure is as reliable as ambulatory blood pressure in predicting target-organ damage in hypertension. Am J Hypertens 2007; 20: 616–621.
Matsui Y, Eguchi K, Ishikawa J, Hoshide S, Shimada K, Kario K . Subclinical arterial damage in untreated masked hypertensive subjects detected by home blood pressure measurement. Am J Hypertens 2007; 20 (4): 385–391.
Angeli F, Reboldi G, Verdecchia P . Masked hypertension: evaluation, prognosis, and treatment. Am J Hypertens 2010; 23 (9): 941–948.
Myers MG, Godwin M, Dawes M, Kiss A, Tobe SW, Grant FC et al. Conventional versus automated measurement of blood pressure in primary care patients with systolic hypertension: randomised parallel design controlled trial. BMJ 2011; 342: d286.
Myers MG, Godwin M, Dawes M, Kiss A, Tobe SW, Kaczorowski J . The conventional versus automated measurement of blood pressure in the office (CAMBO) trial: masked hypertension sub-study. J Hypertens 2012; 30 (10): 1937–1941.
National Clinical Guideline Centre (UK). Hypertension: The Clinical Management of Primary Hypertension in Adults: Update of Clinical Guidelines 18 and 34. Royal College of Physicians (UK): London, UK, 2011.
Hanninen M-RA, Niiranen TJ, Puukka PJ, Mattila AK, Jula AM . Determinants of masked hypertension in the general population: the Finn-Home study. J Hypertens 2011; 29: 1880–1888.
Turnbull F, Neal B, Algert C, Chalmers J, Woodward M, Macmahon S et al. Effects of ACE inhibitors, calcium antagonists, and other blood-pressure-lowering drugs: results of prospectively designed overviews of randomised trials. Lancet 2000; 356 (9246): 1955–1964.
Hare JL, Sharman JE, Leano R, Jenkins C, Wright L, Marwick TH . Impact of spironolactone on vascular, myocardial, and functional parameters in untreated patients with a hypertensive response to exercise. Am J Hypertens 2013; 26: 691–699.
Mancia G, Bombelli M, Facchetti R, Madotto F, Quarti-Trevano F, Friz HP et al. Long-term risk of sustained hypertension in white-coat or masked hypertension. Hypertension 2009; 54 (2): 226–232.
Hanninen M-RA, Niiranen TJ, Puukka PJ, Johansson J, Jula AM . Prognostic significance of masked and white-coat hypertension in the general population: the Finn-Home Study. J Hypertens 2012; 30: 705–712.
Acknowledgements
This work was supported by P01-HL047540 (PI: to JES) and R01 HL098604 (PI: to AJV) from the National Heart, Lung and Blood Institute at the National Institutes of Health (NIH). The research was also supported by T32-HL007854-15, General Clinical Research Center Grant MO1-RR10710 (to Stony Brook University), an NIH Diversity Supplement P01-HL047540-19S1 (to KMD) and the National Center for Advancing Translational Sciences, NIH, through Grant Number UL1 TR000040, formerly the National Center for Research Resources, Grant Number UL1 RR024156. The contents are solely the responsibility of the authors and do not necessarily represent the official view of NIH.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Competing interests
The authors declare no conflict of interest.
Rights and permissions
About this article
Cite this article
Peacock, J., Diaz, K., Viera, A. et al. Unmasking masked hypertension: prevalence, clinical implications, diagnosis, correlates and future directions. J Hum Hypertens 28, 521–528 (2014). https://doi.org/10.1038/jhh.2014.9
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1038/jhh.2014.9
This article is cited by
-
The prevalence of masked hypertension in patients with lone atrial fibrillation: a cross sectional analytical study
Scientific Reports (2023)
-
Assessing cardiovascular parameters and risk factors in physical therapy practice: findings from a cross-sectional national survey and implication for clinical practice
BMC Musculoskeletal Disorders (2022)
-
Use of Self-Measured Blood Pressure Monitoring to Improve Hypertension Equity
Current Hypertension Reports (2022)
-
Usefulness of ambulatory blood pressure measurement for hypertension management in India: the India ABPM study
Journal of Human Hypertension (2020)
-
Die maskierte Hypertonie - eine diagnostische Herausforderung
CardioVasc (2020)